In April 2026, I’ll be taking on the London Landmarks Half Marathon, running 13.1 miles through the heart of the capital to raise funds for Brain Tumour Research—a cause that’s deeply personal to me.

My own diagnosis of a pilocytic astrocytoma was a huge shock. In 2023 after an accidental fall and a trip to A&E a tumour was found within my left lateral ventricle and was around 4.5cm in size. Due to my discovery being an incidental finding I was lucky to be diagnosed and undergo surgery before it caused more harm. After my surgery I had to slowly gather strength to walk and run again with lasting issues in my leg from the surgery. Even with these pains I have managed to build myself up to still enjoy running at my own pace. My tumour is benign but that does not mean fine, with all tumours deserving of research and funding.

My life will never be the same again as for so many people and family's of people with brain tumours. But I intend to try and make a small difference and aid progress. I have learnt so much about brain tumours and the amazing work being done to make a difference. I have learnt how underfunded and under-researched this disease truly is leading to long roads to diagnose and treatment. I’m running to change that—to help fund the world-class research that could lead to earlier diagnoses, better treatments, and ultimately, a cure.

Thank you so much in advance for donating whatever you can spare, it really will make a massive difference. I am grateful for any support.

Here are some facts to highlight the importance of supporting brain tumour research.

- Brain tumours receive just 1% of the national cancer research funding in the UK, despite being the biggest cancer killer of children and adults under 40.

- Every day, 34 people in the UK are diagnosed with a brain tumour.

- The five-year survival rate for malignant brain tumours is less than 20%, compared to over 80% for many other cancers.

- Brain tumours are notoriously difficult to treat due to their location, heterogeneity, and resistance to conventional therapies.

- Research into gliomas—especially high-grade forms like glioblastoma—is urgently needed to uncover new therapeutic targets and improve outcomes